Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study von Van Den Neste, E, Schmitz, N, Mounier, N, Gill, D, Linch, D, Trneny, M, Bouadballah, R, Radford, J, Bargetzi, M, Ribrag, V, Dührsen, U, Ma, D, Briere, J, Thieblemont, C, Bachy, E, Moskowitz, C H, Glass, B, Gisselbrecht, C

Volltext

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial von Hallek, M, Prof, Fischer, K, MD, Fingerle-Rowson, G, MD, Fink, AM, MD, Busch, R, Mayer, J, Prof, Hensel, M, Prof, Hopfinger, G, MD, Hess, G, MD, von Grünhagen, U, MD, Bergmann, M, MD, Catalano, J, MD, Zinzani, PL, Prof, Caligaris-Cappio, F, Prof, Seymour, JF, Prof, Berrebi, A, Prof, Jäger, U, Prof, Cazin, B, MD, Trneny, M, MD, Westermann, A, Wendtner, CM, Prof, Eichhorst, BF, MD, Staib, P, MD, Bühler, A, MD, Winkler, D, MD, Zenz, T, MD, Böttcher, S, MD, Ritgen, M, MD, Mendila, M, MD, Kneba, M, Prof, Döhner, H, Prof, Stilgenbauer, S, Prof

Volltext

Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study von Van Den Neste, E, Schmitz, N, Mounier, N, Gill, D, Linch, D, Trneny, M, Milpied, N, Radford, J, Ketterer, N, Shpilberg, O, Dührsen, U, Ma, D, Brière, J, Thieblemont, C, Salles, G, Moskowitz, C H, Glass, B, Gisselbrecht, C

Volltext

Treatment of Older Patients with Mantle-Cell Lymphoma von Kluin-Nelemans, H.C, Hoster, E, Hermine, O, Walewski, J, Trneny, M, Geisler, C.H, Stilgenbauer, S, Thieblemont, C, Vehling-Kaiser, U, Doorduijn, J.K, Coiffier, B, Forstpointner, R, Tilly, H, Kanz, L, Feugier, P, Szymczyk, M, Hallek, M, Kremers, S, Lepeu, G, Sanhes, L, Zijlstra, J.M, Bouabdallah, R, Lugtenburg, P.J, Macro, M, Pfreundschuh, M, Procházka, V, Di Raimondo, F, Ribrag, V, Uppenkamp, M, André, M, Klapper, W, Hiddemann, W, Unterhalt, M, Dreyling, M.H

Volltext

Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study von Rule, S, Jurczak, W, Jerkeman, M, Rusconi, C, Trneny, M, Offner, F, Caballero, D, Joao, C, Witzens-Harig, M, Hess, G, Bence-Bruckler, I, Cho, S-G, Thieblemont, C, Zhou, W, Henninger, T, Goldberg, J, Vermeulen, J, Dreyling, M

Volltext

Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation von Martínez, C., Canals, C., Sarina, B., Alessandrino, E.P., Karakasis, D., Pulsoni, A., Sica, S., Trneny, M., Snowden, J.A., Kanfer, E., Milpied, N., Bosi, A., Guidi, S., de Souza, C.A., Willemze, R., Arranz, R., Jebavy, L., Hellmann, A., Sibon, D., Oneto, R., Luan, J.J., Dreger, P., Castagna, L., Sureda, A.

Volltext

Microbiota diversity in patients with Diffuse Large B‐Cell Lymphoma and Immune‐Privileged Sites Lymphoma von Dlouha, L., Tenglerova, M., Rehakova, J., Brichova, M., Kostovcik, M., Benesova, K., Kverka, M., Heissigerova, J., Svozilkova, P., Ondeckova, I., Senavova, J., Herman, V., Kostovcikova, K., Trneny, M.

Volltext

Clinical value of ALK and CD30 expression in mature systemic T cell lymphomas: analysis from the Czech Lymphoma Study Group database (NIHIL) von Janikova, A., Michalka, J., Chloupkova, R., Kopalova, N., Campr, V., Kamaradova, K., Kren, L., Belada, D., Benesova, K., Dlouha, J., Klener, P., Procházka, V., Mocikova, H., Duras, J., Trneny, M.

Volltext

Positron emission tomography at the end of first-line therapy and during follow-up in patients with Hodgkin lymphoma: a retrospective study von Mocikova, H., Obrtlikova, P., Vackova, B., Trneny, M.

Volltext

BRENTUXIMAB VEDOTIN IN COMBINATION WITH CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED CD30‐POSITIVE PERIPHERAL T‐CELL LYMPHOMAS: REAL‐WORLD DATA von Klanova, M., Sykorova, A., Janikova, A., Mocikova, H., Duras, J., Prochazka, V., Pukyova, J., Klener, P., Belada, D., Kopalova, N., Benesova, K., Campr, V., Blahovcova, P., Trneny, M.

Volltext

HOW WE ARE SUCCESSFUL IN THERAPY OF T‐CELL LYMPHOMA PATIENTS (≥70 YEARS). REAL‐WORDL ANALYSIS FROM THE CZECH LYMPHOMA STUDY GROUP REGISTRY (NIHIL) von Janikova, A., Klanova, M., Belada, D., Chloupkova, R., Campr, V., Kamaradova, K., Kopalova, N., Benesova, K., Prochazka, V., Mocikova, H., Duras, J., Trneny, M.

Volltext

ANALYSIS OF PATIENTS IN THE FIRST RELAPSE OR PROGRESSION OF T‐CELL LYMPHOMA. REAL WORLD DATA FROM CZECH LYMPHOMA STUDY GROUP REGISTRY (NIHIL) von Janikova, A., Belada, D., Klanova, M., Chloupkova, R., Kopalova, N., Campr, V., Kamaradova, K., Prochazka, V., Benesova, K., Mocikova, H., Duras, J., Trneny, M.

Volltext

Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and... von Dietrich, S., Boumendil, A., Finel, H., Avivi, I., Volin, L., Cornelissen, J., Jarosinska, R.J., Schmid, C., Finke, J., Stevens, W.B.C., Schouten, H.C., Kaufmann, M., Sebban, C., Trneny, M., Kobbe, G., Fornecker, L.M., Schetelig, J., Kanfer, E., Heinicke, T., Pfreundschuh, M., Diez-Martin, J.L., Bordessoule, D., Robinson, S., Dreger, P.

Volltext

PD-1, PD-L1 and PD-L2 Expression in Mantle Cell Lymphoma and Healthy Population von Karolova, J., Radek, M., Helman, K., Spacek, M., Trneny, M., Klener, P.

Volltext

Cyclin D1 mRNA as a molecular marker for minimal residual disease monitoring in patients with mantle cell lymphoma von Lokvenc, M., Kalinova, Marketa, Forsterova, K., Klener, P., Trneny, M., Fronkova, E., Kodet, R.

Volltext

5-Azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity von Curik, N, Burda, P, Vargova, K, Pospisil, V, Belickova, M, Vlckova, P, Savvulidi, F, Necas, E, Hajkova, H, Haskovec, C, Cermak, J, Krivjanska, M, Trneny, M, Laslo, P, Jonasova, A, Stopka, T

Volltext

Obinutuzumab for the First-Line Treatment of Follicular Lymphoma von Marcus, Robert, Davies, Andrew, Ando, Kiyoshi, Klapper, Wolfram, Opat, Stephen, Owen, Carolyn, Phillips, Elizabeth, Sangha, Randeep, Schlag, Rudolf, Seymour, John F, Townsend, William, Trněný, Marek, Wenger, Michael, Fingerle-Rowson, Günter, Rufibach, Kaspar, Moore, Tom, Herold, Michael, Hiddemann, Wolfgang

Volltext

PERIPHERAL T‐CELL LYMPHOMAS INVOLVING CENTRAL NERVOUS SYSTEM: A REPORT FROM THE CZECH LYMPHOMA STUDY GROUP REGISTRY von Mocikova, H., Pytlik, R., Benesova, K., Janikova, A., Duras, J., Sykorova, A., Steinerova, K., Prochazka, V., Campr, V., Belada, D., Dlouha, J., Trneny, M.

Volltext

INMIND: A PHASE 3 STUDY OF TAFASITAMAB + LENALIDOMIDE AND RITUXIMAB VS PLACEBO + LENALIDOMIDE AND RITUXIMAB FOR RELAPSED/REFRACTORY FOLLICULAR OR MARGINAL ZONE LYMPHOMA von Hübel, K., Scholz, C. W., Luminari, S., Salar, A., Wahlin, B. E., Gopal, A. K., Bonnet, C., Trneny, M., Paneesha, S., Manzke, O., Seguy, F., Li, D., Sehn, L. H.

Volltext

SAFETY AND EFFICACY OF CD37‐TARGETING NARATUXIMAB EMTANSINE PLUS RITUXIMAB IN DIFFUSE LARGE B‐CELL LYMPHOMA AND OTHER NON‐HODGKIN’S B‐CELL LYMPHOMAS – A PHASE 2 STUDY von Levy, M. Y., Grudeva‐Popova, Z., Trneny, M., Jurczak, W., Pylypenko, H., Jagadeesh, D., Andre, M., Nasta, S., Rechavi‐Robinson, D., Toffanin, S., Micallef, S., Attinger, A., Rouits, E., Dymkowska, M., Nauwelaerts, H., Woei‐A‐Jin, F. J. S. H.

Volltext